Cardiac Implant Devices Market Size, Share, Opportunities, And Trends By Product Type (Implantable Closure Devices, Pacemaker Implants, Implantable Cardioverter Defibrillator (ICD), Left Atrial Appendage (LAA) Closure Device, Coronary Stents, Prosthetic Heart Valves, Insertable Cardiac Monitor (ICM), Implantable Heart Pump, Total Artificial Heart, Others), And By Geography – Forecasts From 2025 To 2030

Cardiac Implant Devices Market Size:

The Cardiac Implant Devices Market will reach US$47.741 billion in 2030 from US$33.276 billion in 2025 at a CAGR of 7.49% during the forecast period.

Cardiac Implant Devices Market Trends:

The rising prevalence of cardiac diseases is the major driver of the cardiac implant devices market. The growing ageing population is further augmenting the cases of several heart diseases, thus positively impacting the growth of the cardiac implant devices market. However, the high cost of these devices is currently restraining the growth of cardiac implant devices. Technological advancements to develop advanced cardiac implant devices will continue to propel the growth of the cardiac implant devices market during the forecast period. Geographically, North America holds the major market share on account of the growing geriatric population and high disposable income. APAC will witness the fastest regional market growth on account of the rising incidence of cardiovascular diseases in countries like China and India.

By product type, the cardiac implant devices market is segmented as Implantable Closure Devices, Pacemaker Implants, Implantable Cardioverter Defibrillator (ICD), Left Atrial Appendage (LAA) Closure Devices, Coronary Stents, Prosthetic Heart Valves, Insertable Cardiac Monitor (ICM), Implantable Heart Pump, and Total Artificial Heart. The coronary stents segment is expected to hold a significant CAGR during the forecast period on account of the growing prevalence of coronary heart diseases worldwide. Furthermore, an implantable heart pump is expected to hold a significant market share because of growing health concerns and an increasing number of hearing failures.

By geography, the cardiac implant devices market is segmented as North America, South America, Europe, Middle East and Africa, and the Asia Pacific. Geographically, the global cardiac implant devices market has been segmented into North America, South America, Europe, Middle East and Africa, and the Asia Pacific. These regions have been further segmented into countries which hold a significant share in the market. North America and Europe together hold a significantly large share in this market. The growth in these regions is majorly attributed to state-of-the-art healthcare infrastructure which is expected to continue improving as industry players continue to funnel in huge investments in this sector in these regions. The market in the Asia Pacific is being driven by supportive initiatives by some governments in order to make expensive healthcare services accessible for people of all income groups. The Middle East and Africa, and South America are also expected to show good growth over the projected period.

The global cardiac implant devices market report provides an in-depth analysis of the industry landscape, delivering strategic and executive-level insights backed by data-driven forecasts and analysis. This regularly updated report equips decision-makers with actionable intelligence on current market trends, emerging opportunities, and competitive dynamics. It examines demand across various cardiac implant devices and technologies, such as pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices, while exploring applications across cardiovascular disease management, arrhythmia treatment, and heart failure therapy. The report also investigates technological advancements, key government policies, regulations, and macroeconomic factors, offering a comprehensive view of the market.

Cardiac Implant Devices Market Segmentations:

Cardiac Implant Devices Market Segmentation by product type

The market is analyzed by product type into the following:

• Implantable Closure Devices
• Pacemaker Implants
• Implantable Cardioverter Defibrillator (ICD) 
• Left Atrial Appendage (LAA) Closure Device
• Coronary Stents
• Prosthetic Heart Valves
• Insertable Cardiac Monitor (ICM)
• Implantable Heart Pump
• Total Artificial Heart
• Others

Cardiac Implant Devices Market Segmentation by regions:

The study also analysed the cardiac implant devices market into the following regions, with country level forecasts and analysis as below:

• North America (US, Canada, and Mexico)
• South America (Brazil, Argentina, and Others)
• Europe (Germany, UK, France, Spain, and Others
• Middle East and Africa (Saudi Arabia, UAE, and Others)
• Asia Pacific (China, Japan, India, South Korea, Thailand, Indonesia, and Others)

Cardiac Implant Devices Market Competitive Landscape:

The global cardiac implant devices market features key players such as Medtronic, Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, and Biotronik SE & Co. KG, among others. 

Cardiac Implant Devices Market Report Coverage:

This report provides extensive coverage as explained in the points below:

• Market size, forecasts, and trends by different types, with historical revenue data and analysis focusing on key factors driving adoption, current challenges faced by key players, and major growth areas.
• Market size, forecasts, and trends by product type, with historical revenue data and analysis.
• Cardiac implant devices market is also analysed across different regions, with historical data, regional share, attractiveness and opportunity of these solutions in different countries. The growth prospects and key players operating in these markets. The section also dwells on the macro factors, economic scenario and other complementing factors aiding in market growth. 
• Market dynamics: The section details the market growth factors, restraints, and opportunities in the market. The segment also presents complete market scenario with the help of Porter’s five forces model. 
• Competitive Intelligence: A thorough investigation on the competitive structure of the market presented through proprietary vendor matrix model, market share analysis of key players, insights on strategies of key players and recent major developments undertaken by the companies to gain competitive edge. 
• Research methodology: The assumptions and sources which were considered to arrive at the final market estimates. Additionally, how our model is refined to ensure most significant factors are taken into consideration with the proper hypothesis and bottom-up and top-down approaches enhance the reliability of forecasts further strengthening the trustworthiness of the numbers being presented. 

How this report is helpful to you and reasons for purchase?

• The report provides a strategic outlook of the cardiac implant devices market to the decision-makers, analysts and other stakeholders in the easy-to-read format for taking informed decisions.
• The charts, tables and figures make it easy for the executives to gain valuable insights while skimming the report. 
• Analyst support through calls and email for timely clarification and incorporating additional requests. 
• Option of presentation or doc format with the estimates file to take care of diverse requirements. 
• 15% FREE customization with all our reports help cater additional requirements with significant cost-savings. 
• Option of purchasing specific segments of the study, including opting for summary reports or just the estimates file. 

Cardiac Implant Devices Market Scope:

 

Report Metric	Details
Cardiac Implant Devices Market Size in 2025	US$33.276 billion
Cardiac Implant Devices Market Size in 2030	US$47.741 billion
Growth Rate	CAGR of 7.49%
Study Period	2020 to 2030
Historical Data	2020 to 2023
Base Year	2024
Forecast Period	2025 – 2030
Forecast Unit (Value)	USD Billion
Segmentation	Product Type Geography
Geographical Segmentation	North America, South America, Europe, Middle East and Africa, Asia Pacific
List of Major Companies in the Cardiac Implant Devices Market	Medtronic Abbott Laboratories Boston Scientific Corporation Edwards Lifesciences Corporation Biotronik SE & Co. KG
Customization Scope	Free report customization with purchase

 

Our Best-Performing Industry Reports:

• Cardiovascular Care Market
• Cardiac Mapping Market
• Active Implantable Medical Devices (AIMD) Market

---

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. CARDIAC IMPLANT DEVICES MARKET BY PRODUCT TYPE

5.1. Introduction

5.2. Optical microscope

5.3. Implantable Closure Devices

5.4. Pacemaker Implants

5.5. Implantable Cardioverter Defibrillator (ICD) 

5.6. Left Atrial Appendage (LAA) Closure Device

5.7. Coronary Stents

5.8. Prosthetic Heart Valves

5.9. Insertable Cardiac Monitor (ICM)

5.10. Implantable Heart Pump

5.11. Total Artificial Heart

5.12. Others

6. CARDIAC IMPLANT DEVICES MARKET BY GEOGRAPHY

6.1. Introduction

6.2. North America

6.2.1. USA

6.2.2. Canada

6.2.3. Mexico

6.3. South America

6.3.1. Brazil

6.3.2. Argentina

6.3.3. Others

6.4. Europe

6.4.1. United Kingdom

6.4.2. Germany

6.4.3. France

6.4.4. Italy

6.4.5. Spain

6.4.6. Others

6.5. Middle East and Africa

6.5.1. Saudi Arabia

6.5.2. UAE

6.5.3. Others

6.6. Asia Pacific

6.6.1. China

6.6.2. Japan

6.6.3. India

6.6.4. South Korea

6.6.5. Taiwan

6.6.6. Thailand

6.6.7. Indosneisa

6.6.8. Others

7. COMPETITIVE ENVIRONMENT AND ANALYSIS

7.1. Major Players and Strategy Analysis

7.2. Market Share Analysis

7.3. Mergers, Acquisitions, Agreements, and Collaborations

7.4. Competitive Dashboard

8. COMPANY PROFILES

8.1. Medtronic 

8.2. Abbott Laboratories 

8.3. Boston Scientific Corporation

8.4. Edwards Lifesciences Corporation

8.5. Biotronik SE & Co. KG

8.6. LivaNova PLC

8.7. Lepu Medical Technology Co., Ltd.

8.8. Asahi Kasei Corporation 

8.9. Stryker Corporation 

8.10. Abiomed, Inc.

8.11. SynCardia Systems, LLC

9. APPENDIX

9.1. Currency 

9.2. Assumptions

9.3. Base and Forecast Years Timeline

9.4. Key benefits for the stakeholders

9.5. Research Methodology 

9.6. Abbreviations 

LIST OF FIGURES

LIST OF TABLES

Medtronic 

Abbott Laboratories 

Boston Scientific Corporation

Edwards Lifesciences Corporation

Biotronik SE & Co. KG

LivaNova PLC

Lepu Medical Technology Co., Ltd.

Asahi Kasei Corporation 

Stryker Corporation

Abiomed, Inc.

SynCardia Systems, LLC